title: Eltrombopag: liver toxicity, kidney injury or assay interference?
authors: Department of Pathology, Monash Medical Centre, Australia. Electronic address: kay.choy@monashhealth.org.
authors: Kay Weng
authors: KW
authors: Choy
authors: Department of Pathology, Monash Medical Centre, Australia; Department of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia; Dorevitch Pathology, Heidelberg, Vic, Australia.
authors: Nilika
authors: N
authors: Wijeratne
authors: Department of Pathology, Monash Medical Centre, Australia; Department of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
authors: James C G
authors: JC
authors: Doery
mesh_terms: D001565:Benzoates / Q000009:adverse effects* / Q000097:blood; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D003404:Creatinine / Q000097:blood; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects* / Q000097:blood; D007668:Kidney / Q000187:drug effects* / Q000293:injuries; D007677:Kidney Function Tests; D008111:Liver Function Tests; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D011720:Pyrazoles / Q000009:adverse effects* / Q000097:blood
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D003404:Creatinine; D001663:Bilirubin; C520809:eltrombopag